UBS lowered the firm’s price target on ArcBest (ARCB) to $77 from $80 and keeps a Neutral rating on the shares. ArcBest repoted upside to Q3 on the cost side, but guidance for Q4 was softer due to weaker volume, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARCB: